PROFUND ADVISORS LLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,486,037
-2.0%
122,207
+1.2%
0.08%
+1.2%
Q2 2023$1,516,356
+20.5%
120,729
+6.4%
0.08%
+3.8%
Q1 2023$1,258,061
+335.5%
113,441
+379.5%
0.08%
+310.5%
Q4 2022$288,864
+24.0%
23,658
+6.1%
0.02%
+11.8%
Q3 2022$233,000
-4.1%
22,291
-1.5%
0.02%
+13.3%
Q2 2022$243,000
+11.5%
22,640
-1.5%
0.02%
+66.7%
Q1 2022$218,000
-23.2%
22,991
-6.6%
0.01%0.0%
Q4 2021$284,000
+29.7%
24,627
+7.6%
0.01%
+28.6%
Q3 2021$219,000
-16.4%
22,892
-16.0%
0.01%
-22.2%
Q2 2021$262,000
+6.5%
27,252
+9.5%
0.01%0.0%
Q1 2021$246,000
-54.7%
24,881
+5.8%
0.01%
-62.5%
Q4 2020$543,000
+73.5%
23,509
+6.2%
0.02%
+50.0%
Q3 2020$313,000
-10.8%
22,138
-5.0%
0.02%
-20.0%
Q2 2020$351,000
+74.6%
23,302
+7.2%
0.02%
+33.3%
Q1 2020$201,000
-16.9%
21,731
-12.4%
0.02%
+36.4%
Q4 2019$242,000
+47.6%
24,809
+21.3%
0.01%
+37.5%
Q3 2019$164,000
-42.5%
20,457
-10.5%
0.01%
-42.9%
Q2 2019$285,000
+3.3%
22,860
+12.5%
0.01%
+7.7%
Q1 2019$276,000
+4.9%
20,314
-25.9%
0.01%
-18.8%
Q4 2018$263,000
-42.3%
27,430
-27.2%
0.02%
-5.9%
Q3 2018$456,00037,6810.02%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders